These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23917314)

  • 1. Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient.
    Tazi A; Chapron J; Touak G; Longo M; Hubert D; Collobert G; Dusser D; Poyart C; Morand PC
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5186-8. PubMed ID: 23917314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.
    Román F; Roldán C; Trincado P; Ballesteros C; Carazo C; Vindel A
    Antimicrob Agents Chemother; 2013 May; 57(5):2428-9. PubMed ID: 23459489
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
    J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype.
    Ba BB; Arpin C; Bikie Bi Nso B; Dubois V; Saux MC; Quentin C
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1443-52. PubMed ID: 20100878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients.
    Hill RL; Kearns AM; Nash J; North SE; Pike R; Newson T; Woodford N; Calver R; Livermore DM
    J Antimicrob Chemother; 2010 Mar; 65(3):442-5. PubMed ID: 20089543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.
    Endimiani A; Blackford M; Dasenbrook EC; Reed MD; Bajaksouszian S; Hujer AM; Rudin SD; Hujer KM; Perreten V; Rice LB; Jacobs MR; Konstan MW; Bonomo RA
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1684-92. PubMed ID: 21263048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
    Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
    Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
    J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis.
    Ferrin M; Zuckerman JB; Meagher A; Blumberg EA
    Pediatr Pulmonol; 2002 Mar; 33(3):221-3. PubMed ID: 11836802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
    Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
    J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.
    Gao W; Chua K; Davies JK; Newton HJ; Seemann T; Harrison PF; Holmes NE; Rhee HW; Hong JI; Hartland EL; Stinear TP; Howden BP
    PLoS Pathog; 2010 Jun; 6(6):e1000944. PubMed ID: 20548948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.
    de Dios Caballero J; Pastor MD; Vindel A; Máiz L; Yagüe G; Salvador C; Cobo M; Morosini MI; del Campo R; Cantón R;
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1878-82. PubMed ID: 26666940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
    Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
    Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
    Arias CA; Vallejo M; Reyes J; Panesso D; Moreno J; Castañeda E; Villegas MV; Murray BE; Quinn JP
    J Clin Microbiol; 2008 Mar; 46(3):892-6. PubMed ID: 18174304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of linezolid-resistant CoNS isolates in Japan.
    Takaya A; Kimura A; Sato Y; Ishiwada N; Watanabe M; Matsui M; Shibayama K; Yamamoto T
    J Antimicrob Chemother; 2015 Mar; 70(3):658-63. PubMed ID: 25381168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
    Miller K; O'Neill AJ; Wilcox MH; Ingham E; Chopra I
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1940-4. PubMed ID: 18378719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.